undamentalytics Newsletter
Sign in

Ryan Specialty Holdings, Inc. (RYAN) stock

Add to watchlist

Add holding +

NYSE: RYAN NYSE Insurance Brokers Next results ~February 11, 2027

C Fundamentals grade

Ryan Specialty Holdings, Inc. is a US-listed company in the insurance brokers industry. Its financial year ends in December.

Stock price today

Loading chart…

Third-party market data · may be delayed

Model estimate per share

~$46

Forward price-to-earnings vs peers

Base case. Range ~$38–$55. Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings.

Price vs value

No Buy/Hold/Sell rating is issued: only 1 valuation models apply; a rating needs 3.

Ryan Specialty Holdings, Inc. valuation: adjust assumptions and compare models →

Who’s trading

What company insiders, investment funds and members of Congress have been doing with the stock, from their own filings.

  • Insiders6 buying, 4 selling9 purchases and 4 sales by directors and officers, last 12 monthsInsider trades
  • Funds189 adding, 205 cuttingOf 60 active managers that changed their stake, 23 added; quarter to June 30, 2026Fund buyers and sellers

Value diary

Our note on each quarter Ryan Specialty Holdings files

10-Q filed October 30: Ryan Specialty

Model value −8.0%

Revenue for the twelve months to September 2026 was $3.25bn, up 9.8% on a year earlier, slower than the 14.4% growth a quarter earlier. Our model value falls from $10.56 to $9.71 a share, against a share price of $43.84.

Source: 10-Q filed October 30, 2026 on SEC EDGAR · Financials · Valuation

Earlier notes (2)

10-Q filed July 31: Ryan Specialty

Ryan Specialty's revenue reached $3.25bn in the twelve months to June 2026, a 9.8% rise on the prior year. That pace has cooled markedly from the 14.4% growth recorded just a quarter earlier, pointing to a clear deceleration in the underlying business. Our model value has moved sharply lower as a result, falling from $25.40 to $10.56 a share. Against a current share price of $43.09, the gap between market pricing and modelled value is now substantial. The slowdown in top-line growth appears to be the key driver behind the revised valuation. Whether this marks a temporary soft patch or a more lasting shift in growth will likely shape how the shares trade from here.

10-Q on SEC EDGAR

Where Ryan Specialty stands after its latest 10-Q

Revenue for the twelve months to June 2026 was $3.22bn, up 14.4% on a year earlier, slower than 18.9% a quarter earlier. Our valuation models combined value is $18.26 a share, against a share price of $42.05.

10-Q on SEC EDGAR

Written from the company's filings and our models when each quarter's report arrives. Figures in older notes are as published at the time. Not investment advice.

The Fundamentalytics view

Next results ~February 11, 2027 (estimated)

Ryan Specialty Holdings, Inc.'s trailing-twelve-month revenue grew 9.8% year on year, with a free-cash-flow margin of 17.5%. Where it lags: change in growth rate of -4.6pp ranks 14 of 17 insurance brokers companies we cover.

Current signal Free cash flow diverging from earnings: TTM free cash flow fell 10.7% while net income grew 51.2%: a 62pp divergence.

Assembled from SEC-filed figures — the full workings are on this page and in our methodology. Observations, not recommendations.

Highlights

How we pick these

Strengths

Nothing in Ryan Specialty Holdings, Inc.'s latest figures clears our strength thresholds.

Things to watch

  • Growth easing. The growth rate is 4.6 points lower than a quarter earlier.
  • Below peers: change in growth rate. Change in growth rate of -4.6pp ranks 14 of 17 insurance brokers companies we cover (median -0.7pp).
  • Heavily shorted. 13.3% of the shares available to trade are sold short (6.6 days of average volume to cover).

Latest results: FY2026 Q3

Filed October 30, 2026
Earnings per share
$0.51 against an average estimate of $0.49: beat by 5.0%
Revenue
$790m, up 4.7% on a year earlier
Share reaction
+2.9% in the first session after the results on October 29, 2026, against -2.1% for the S&P 500
Guidance given
adjusted EBITDAC Margin 50 to 100 (full year 2026)
Next report
October 29, 2026; average EPS estimate $0.48

Ryan Specialty Holdings' figures from its SEC filings and results release; estimates are the analysts' average. Not a recommendation.

Price chart

  • 1 day+3.7%
  • 1 week+2.3%
  • 1 month+20.7%
  • This year-11.0%
  • 1 year-16.0%
  • 5 years+27.1%
  • S&P 500 this year+11.2%

Closing prices to 2026-11-02. Price change only, dividends excluded.

Loading chart…

Third-party market data · may be delayed

At a glance

Trailing twelve months, from SEC filings

Profitability

Revenue (TTM)
$3.3B
Operating margin
15.6%
Net margin
3.2%

Growth

Revenue growth
+9.8%
Change in growth rate
−4.6 pts

Earnings

Last results
October 29, 2026
Next results (est.)
February 11, 2027

News & updates

Updated October 31, 2026

Company announcements, filed results and changes that matter to shareholders.

  1. Results
  2. Results
  3. Insider trade
  4. Agreement
  5. Results
  6. Guidance

Refreshed hourly when new source data is available. Summaries are checked against company releases and SEC filings. Company announcement headlines are labelled when a checked summary is unavailable.

Valuation

Ryan Specialty Holdings, Inc. valuation models and calculator

Fundamentalytics rating

model v1.6 · 2026-11-03

Not rated: only 1 valuation models apply; a rating needs 3.

Valuation models

We value Ryan Specialty Holdings, Inc. as an asset manager, broker or exchange, with every model that fits that kind of business. Cost of equity 7.4%: the 10-year Treasury yield (4.9%) plus a beta of 0.55 times a 4.5% equity risk premium.

Value per share by model
Model Value per share In the combined value?
Forward price-to-earnings vs peers Next year's consensus earnings per share times peers' typical (harmonic-mean) forward price-to-earnings. Uses analysts' consensus estimates (third-party data), not our forecasts. ~$46 ~$38–$55 Primary model, counts double
Residual income Book value plus the present value of returns above the cost of equity, fading over ten years. ~$6.8 ~$4.8–$9.8 Left out: out of range vs price (0.15x)
Justified price-to-book Book value times (return on equity - growth) / (cost of equity - growth): steady-state returns. ~$8.3 ~$6.7–$11 Left out: out of range vs price (0.18x)
Price-to-book vs peers Book value per share times peers' typical (harmonic-mean) price-to-book. ~$0.9 ~$1.3–$15 Left out: out of range vs price (0.02x)
Dividend discount (two-stage) Dividends for five years at the growth the business can fund, then a steady payout and growth. ~$9.0 ~$7.3–$12 Left out: out of range vs price (0.20x)
Combined value Weighted average of the models that apply: the primary model (forward price-to-earnings vs peers) counts double. Models more than 5x or less than 0.2x the share price, or more than 3x away from the other models' median, are left out. ~$46 ~$38–$55 1 model

Different models fail in different ways, so where several apply we average them rather than trust one. Peer-based models compare Ryan Specialty Holdings, Inc. with insurance brokers in our coverage, using third-party market data. Model values are estimates under stated assumptions, updated as new filings arrive; not price targets or investment advice. How each model works.

Moat

Not assessed: fewer than five years of comparable figures in the filings. AI disruption exposure for this industry: High.

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Forecasts and guidance

Analysts' consensus

Fiscal yearEPSGrowthRevenueGrowth
Current $2.16 +11% $3.3bn +8%
Next $2.44 +13% $3.5bn +7%

Next year's EPS estimate has moved +3.5% in 90 days, across 19 analysts.

How the EPS forecast has moved

The consensus EPS forecast for the current fiscal year is +5.1% on 90 days ago. In the last 30 days, 4 analysts raised Ryan Specialty Holdings, Inc.'s forecast and 2 cut it.

Consensus EPS forecast Ryan Specialty Holdings, Inc., last 90 days
$2.00 $2.10 $2.20 $2.30 $2.40 $2.50 90 days ago 60 days ago 30 days ago 7 days ago Now Current fiscal year, 90 days ago: $2.06 Current fiscal year, 60 days ago: $2.17 Current fiscal year, 30 days ago: $2.17 Current fiscal year, 7 days ago: $2.16 Current fiscal year, Now: $2.16 $2.16 Next fiscal year, 90 days ago: $2.35 Next fiscal year, 60 days ago: $2.42 Next fiscal year, 30 days ago: $2.42 Next fiscal year, 7 days ago: $2.44 Next fiscal year, Now: $2.44 $2.44

Average of analysts' published estimates (third-party data).

View chart data
Period Current fiscal yearNext fiscal year
90 days ago $2.06$2.35
60 days ago $2.17$2.42
30 days ago $2.17$2.42
7 days ago $2.16$2.44
Now $2.16$2.44

Earnings against estimates

Quarter toEstimateActualSurprise
Sept 2026 $0.49 $0.51 +5.0%
Jun 2026 $0.60 $0.74 +22.9%
Mar 2026 $0.43 $0.47 +8.7%
Dec 2025 $0.49 $0.45 −8.3%

Adjusted EPS as companies report it, against the average analyst estimate.

Management guidance

Earnings release, July 30, 2026
  • Adjusted EBITDAC Margin full year 2026 50 to 100 Non-GAAP
    “We are guiding to an Adjusted EBITDAC Margin that is down 50 - 100 basis points for 2026, as compared to the prior year” source

Figures and quotations are management's, copied from the company's own press release (SEC 8-K exhibit) and checked word for word against it. Forward-looking statements are the company's expectations, not ours and not advice; guidance can change or be missed.

Analyst recommendations

19 analysts, Oct 2026
Buy947%
Hold947%
Sell15%

Monthly trend

  1. Oct 202645919
  2. Sep 202645919
  3. Aug 202645919
  4. Jul 202645919

Counts of recommendations published by analysts covering Ryan Specialty Holdings, Inc., by month. Source: Aggregated broker recommendations (third-party data). Aggregated counts only: we do not reproduce any firm's recommendation or price target, and these are not Fundamentalytics ratings.

Positioning

Short interest
13.3%
of tradable shares
Days to cover
6.64
at average volume
Short interest, 1 month
+17%
to October 15, 2026
Held by institutions
98%
of shares
Held by insiders
14.6%
of shares
Employees
6,171
full time

Consensus figures average analysts' published estimates (third-party data); guidance is the company's own. Neither is our forecast. Short interest is reported twice a month and lags. Market data may be delayed.

This section is general information, not investment advice or a personal recommendation, and it does not take account of your objectives or circumstances. Forecasts and guidance are estimates, not promises: companies miss their own guidance and analysts' figures are often revised. Prices can fall as well as rise, and you can lose money. See our disclaimer.

Share-price performance

Market data may be delayed

Return and risk by year

Calendar year 20222023202420252026 to date
Return
RYAN+3%+4%+51%−19%−11%
Industry peers (median)−27%+21%+25%−21%−1%
S&P 500−18%+26%+25%+18%+11%
Months that ended higher
RYAN50%42%75%42%46%
S&P 50042%67%75%75%46%
Largest fall from a high during the year
RYAN−30%−19%−16%−33%−44%
S&P 500−25%−10%−8%−19%−9%

Worst fall since July 22, 2021: 61% from April 3, 2025 to May 6, 2026. Getting back needed a 156% gain, and the shares have not yet recovered.

Price behaviour

52-week range
$29.18 – $57.77
From 52-week high
−21.3%
vs 50-day average
+12.4%
vs 200-day average
+17.3%
Volatility (1 year)
44%
Beta vs S&P 500
-0.38

Volatility is the annualised standard deviation of daily returns. Beta 1.5 means the shares typically moved 1.5% for each 1% move in the S&P 500 over the past year. Prices to November 2, 2026.

Share price after results

Next day
5 up, 7 down
typical move ±6.4%
After a week
6 up, 5 down
typical move ±5.7%
After a month
7 up, 4 down
typical move ±9.2%
Results releasedNext dayS&P 500 next day5 days21 days
October 29, 2026 +2.9% −2.1% — —
July 30, 2026 −5.0% +2.4% −4.3% −5.3%
April 30, 2026 −12.6% +1.3% −10.1% −5.7%
February 12, 2026 −10.1% −1.5% −4.1% −15.7%
October 30, 2025 +7.7% −0.8% +11.9% +15.0%
July 31, 2025 −3.8% −2.0% −1.0% −5.8%
May 1, 2025 +2.1% +2.2% +7.1% +10.1%
February 20, 2025 −5.8% −2.1% +1.0% +2.6%
October 30, 2024 −5.9% −2.3% −1.5% +7.9%
August 1, 2024 +11.3% −3.3% +6.3% +5.1%
May 2, 2024 −1.8% +2.2% +1.7% +8.5%
February 27, 2024 +7.8% +0.1% +13.7% +19.1%

From the close before the release date to the close 1, 5 and 21 trading days after it, so releases before the open and after the close are both captured. Past moves don't predict future ones.

Fundamentals

Revenue (TTM) Ryan Specialty Holdings, Inc.
$2B $2.5B $3B $3.5B FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue (TTM), FY23 Q4: $2.1B Revenue (TTM), FY24 Q1: $2.2B Revenue (TTM), FY24 Q2: $2.3B Revenue (TTM), FY24 Q3: $2.4B Revenue (TTM), FY24 Q4: $2.5B Revenue (TTM), FY25 Q1: $2.7B Revenue (TTM), FY25 Q2: $2.8B Revenue (TTM), FY25 Q3: $3B Revenue (TTM), FY25 Q4: $3.1B Revenue (TTM), FY26 Q1: $3.2B Revenue (TTM), FY26 Q2: $3.2B Revenue (TTM), FY26 Q3: $3.3B $3.3B

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue (TTM)
FY23 Q4 $2.1B
FY24 Q1 $2.2B
FY24 Q2 $2.3B
FY24 Q3 $2.4B
FY24 Q4 $2.5B
FY25 Q1 $2.7B
FY25 Q2 $2.8B
FY25 Q3 $3B
FY25 Q4 $3.1B
FY26 Q1 $3.2B
FY26 Q2 $3.2B
FY26 Q3 $3.3B
Revenue growth, TTM YoY Ryan Specialty Holdings, Inc.
5% 10% 15% 20% 25% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Revenue growth, TTM YoY, FY23 Q4: 20.4% Revenue growth, TTM YoY, FY24 Q1: 20.9% Revenue growth, TTM YoY, FY24 Q2: 20.8% Revenue growth, TTM YoY, FY24 Q3: 20.5% Revenue growth, TTM YoY, FY24 Q4: 21.1% Revenue growth, TTM YoY, FY25 Q1: 22.2% Revenue growth, TTM YoY, FY25 Q2: 23.3% Revenue growth, TTM YoY, FY25 Q3: 24.3% Revenue growth, TTM YoY, FY25 Q4: 21.3% Revenue growth, TTM YoY, FY26 Q1: 18.9% Revenue growth, TTM YoY, FY26 Q2: 14.4% Revenue growth, TTM YoY, FY26 Q3: 9.8% 9.8%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Revenue growth, TTM YoY
FY23 Q4 20.4%
FY24 Q1 20.9%
FY24 Q2 20.8%
FY24 Q3 20.5%
FY24 Q4 21.1%
FY25 Q1 22.2%
FY25 Q2 23.3%
FY25 Q3 24.3%
FY25 Q4 21.3%
FY26 Q1 18.9%
FY26 Q2 14.4%
FY26 Q3 9.8%
Operating margin (TTM) Ryan Specialty Holdings, Inc.
14% 15% 16% 17% 18% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 Operating margin (TTM), FY23 Q4: 17.3% Operating margin (TTM), FY24 Q1: 16.7% Operating margin (TTM), FY24 Q2: 17.7% Operating margin (TTM), FY24 Q3: 17.4% Operating margin (TTM), FY24 Q4: 17.0% Operating margin (TTM), FY25 Q1: 17.2% Operating margin (TTM), FY25 Q2: 17.1% Operating margin (TTM), FY25 Q3: 17.3% Operating margin (TTM), FY25 Q4: 16.2% Operating margin (TTM), FY26 Q1: 15.5% Operating margin (TTM), FY26 Q2: 14.8% Operating margin (TTM), FY26 Q3: 15.6% 15.6%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period Operating margin (TTM)
FY23 Q4 17.3%
FY24 Q1 16.7%
FY24 Q2 17.7%
FY24 Q3 17.4%
FY24 Q4 17.0%
FY25 Q1 17.2%
FY25 Q2 17.1%
FY25 Q3 17.3%
FY25 Q4 16.2%
FY26 Q1 15.5%
FY26 Q2 14.8%
FY26 Q3 15.6%
FCF margin (TTM) Ryan Specialty Holdings, Inc.
16% 18% 20% 22% 24% 26% FY23 Q4 FY24 Q3 FY25 Q2 FY26 Q3 FCF margin (TTM), FY23 Q4: 23.0% FCF margin (TTM), FY24 Q1: 24.1% FCF margin (TTM), FY24 Q2: 21.6% FCF margin (TTM), FY24 Q3: 20.9% FCF margin (TTM), FY24 Q4: 20.5% FCF margin (TTM), FY25 Q1: 18.4% FCF margin (TTM), FY25 Q2: 20.3% FCF margin (TTM), FY25 Q3: 21.5% FCF margin (TTM), FY25 Q4: 21.0% FCF margin (TTM), FY26 Q1: 19.5% FCF margin (TTM), FY26 Q2: 17.2% FCF margin (TTM), FY26 Q3: 17.5% 17.5%

Source: SEC EDGAR filings. Retrieved October 30, 2026.

View chart data
Period FCF margin (TTM)
FY23 Q4 23.0%
FY24 Q1 24.1%
FY24 Q2 21.6%
FY24 Q3 20.9%
FY24 Q4 20.5%
FY25 Q1 18.4%
FY25 Q2 20.3%
FY25 Q3 21.5%
FY25 Q4 21.0%
FY26 Q1 19.5%
FY26 Q2 17.2%
FY26 Q3 17.5%

Data: SEC EDGAR XBRL company facts (as filed in 10-K/10-Q); forms 10-K, 10-Q. Generated November 3, 2026. Definitions in our methodology.

Financial statements

US$ millions unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Fiscal year 2019 Dec 2019 2020 Dec 2020 2021 Dec 2021 2022 Dec 2022 2023 Dec 2023 2024 Dec 2024 2025 Dec 2025 LTM Sept 2026
Income
Revenue 765 1,018 1,433 1,725 2,078 2,516 3,051 3,253
EBITDA 106 162 191 295 368 438 507 524
Operating income 101 159 187 290 359 428 494 507
Net income 64 68 66 61 61 95 63 105
Growth (year on year)
Revenue — +33.1% +40.7% +20.4% +20.4% +21.1% +21.3% +9.8%
EBITDA — +53.5% +17.8% +54.2% +24.7% +18.9% +15.8% +0.1%
Operating income — +56.9% +17.7% +55.1% +24.0% +19.1% +15.4% −0.8%
Net income — +6.1% −3.3% −7.3% −0.0% +55.1% −33.0% +51.2%
Margins
EBITDA margin 13.8% 16.0% 13.4% 17.1% 17.7% 17.4% 16.6% 16.1%
Operating margin 13.2% 15.6% 13.0% 16.8% 17.3% 17.0% 16.2% 15.6%
Net margin 8.4% 6.7% 4.6% 3.5% 2.9% 3.8% 2.1% 3.2%
Free-cash-flow margin 19.5% 12.8% −4.9% 19.0% 23.0% 20.5% 21.0% 17.5%
Cash flow
Cash from operations 150 135 273 336 477 515 644 570
Capital spending 0 5 343 8 0 0 3 2
Free cash flow 149 130 −70 328 477 515 641 569
Stock-based pay 8 11 68 77 70 79 69 70
Free cash flow after stock pay 141 119 −137 250 407 436 571 498
Balance sheet
Cash 402 896 1,140 993 839 540 158 169
Total debt 0 1,585 1,641 2,026 2,010 3,332 3,394 3,676
Net debt (negative = net cash) −402 690 501 1,033 1,172 2,792 3,236 3,508
Returned to shareholders
Dividends — — — 0 0 80 61 64
Buybacks 0 0 78 0 0 — — —
Total returned 0 0 78 0 0 80 61 64

Source: SEC EDGAR XBRL company facts (US and foreign periodic filings); column headings link to the filing. EBITDA is operating income plus depreciation and amortisation. Free cash flow is cash from operations minus capital spending. Growth is left blank when last year's figure was a loss or under 2% of revenue. Share counts and EPS are restated for stock splits. A dash means the company didn't report the figure.

Dividends, buybacks and capital spending

Dividends (TTM)
$64.4M
Returned to shareholders
11%
of free cash flow
Total shareholder yield
1.2%
dividends 1.2% + buybacks 0.0% of market value
Dividend payout ratio
62%
of net income paid out

Competitors: side by side with peers

Closest by revenue in insurance brokers
Last 12 months unless stated RYAN ERIE BWIN SLQT BRO HGTY Median
Revenue, last 12 months $3.3bn $4.1bn $1.7bn $1.6bn $6.9bn $1.4bn $1.6bn
Revenue growth, last 12 months 9.8% 2.0% 18.9% 6.0% 26.1% 5.2% 7.6%
Revenue growth, 3-year average 18.0% 9.4% — 17.3% 18.7% 17.1% 13.8%
Revenue growth, latest quarter 4.7% 0.3% 30.1% −6.8% 7.4% −6.5% 4.7%
Operating margin 15.6% 17.9% −6.9% 4.6% — 8.0% 9.4%
Operating margin, 3-year average 16.7% 17.7% 0.4% 4.6% — 3.5% 4.9%
Net margin 3.2% 14.0% −4.7% 3.8% 17.6% 4.9% 4.9%
Cash from operations / revenue 17.5% 16.8% 5.2% 2.0% 22.9% 21.4% 15.5%
Free-cash-flow margin 17.5% 13.4% 2.5% 1.7% 21.5% 19.4% 13.4%
Free-cash-flow margin, 3-year average 20.0% 13.5% −2.4% 0.6% 22.4% 14.5% 13.7%
Stock pay / revenue 2.2% — 4.3% 0.9% 1.3% 1.3% 1.4%
Change in share count — — 23.3% 3.5% 12.3% — 5.7%

Median of all 17 companies we cover in insurance brokers. Shaded: best of the six on that line (lowest for stock pay and share-count growth). 3-year figures average the last three 12-month periods; 3-year growth is compound annual. Source: SEC filings.

Peer comparison

17 insurance brokers companies
Measure Company Peer median Rank
Revenue growth Growth 9.8% 7.6% 8 of 17
Change in growth rate Growth -4.6pp -0.7pp 14 of 17
Operating margin Profitability 15.6% 10.8% 6 of 14
Net margin Profitability 3.2% 4.9% 11 of 17
Stock pay as % of revenue Cash generation 2.2% 1.5% 11 of 16

Rank 1 = best in the group (for spending, debt and dilution, lower ranks first).

Where the revenue comes from

Fiscal year to December 31, 2025
Products and services
Line of business Revenue Share YoY
Wholesale Brokerage $1.6B 53.4% ▲ 7.5%
Underwriting Management $1B 34.2% ▲ 58.5%
Binding Authorities $370M 12.4% ▲ 15.5%
Geography
Region Revenue Share YoY
United States $2.9B 93.9% ▲ 19.7%
Outside the US $187M 6.1% ▲ 51.0%

From Ryan Specialty Holdings, Inc.'s 10-K filed February 13, 2026, as tagged in the filing. View filing. Indented rows are part of the line above; their share is of that line. In the bars, the faint bar behind is the year before.

Who owns it

Funds buying and selling
Reported value
$4.4B
Institutions reporting
365
Shares held vs prior quarter
▲ 5.0%
Positions opened / closed
75 / 71

Top buyers and sellers, Q2 2026: 189 institutions bought and 205 sold ; the biggest buyer was Orbis Allan Gray Ltd (+6.3M shares) and the biggest seller Principal Financial Group Inc (−4.1M). See which funds bought and sold →

Largest reported holders, June 30, 2026
Manager Value Shares Share of 13F value Shares QoQ
Blackrock, Inc. $396M 10.5M 9.0% ▼ 3.5%
Vulcan Value Partners, LLC $299M 7.9M 6.8% ▲ 20.0%
T. Rowe Price Investment Management, Inc. $250M 6.6M 5.7% ▼ 6.7%
Orbis Allan Gray Ltd $238M 6.3M 5.4% New
Neuberger Berman Group LLC $210M 5.6M 4.8% ▲ 79.4%
Vanguard Portfolio Management LLC $199M 5.3M 4.5% ▼ 1.4%
Vanguard Capital Management LLC $197M 5.2M 4.5% ▲ 0.3%
FMR LLC $194M 5.1M 4.4% ▲ 1470.2%
State Street Corp $140M 3.7M 3.2% ▲ 2.0%
Polar Capital Holdings PLC $111M 2.9M 2.5% ▲ 20.0%
Bank Of Montreal $104M 2.8M 2.4% ▲ 20.9%
Stephens Investment Management Group LLC $103M 2.7M 2.3% ▲ 12.1%

From Form 13F filings with the SEC ( quarterly data sets), as reported by each manager for June 30, 2026 and filed up to 45 days later. 13F reports cover long US-listed positions of managers above $100M only, so this is not Ryan Specialty Holdings, Inc.'s complete shareholder register. Values are as reported by the filers ; 2 inconsistently scaled filing rows were excluded.

Insider trading activity

Full insider history and chart
Insider purchases History → $5.6M 9 trades by 6 insiders, last 12 months Insider sales History → $235M 4 trades by 4 insiders · 0% under pre-set plans
Net ▼ $229M net selling
Insider Date Trade Shares Price Value
Mulshine Brendan Martin Co-President and CRO September 8, 2026 Sell 40,000 $40.51 $1.6M
Conklin Michael EVP & CHRO August 13, 2026 Sell 2,043 $42.26 $86,337
Kuczinski Anthony J Director June 12, 2026 Buy 500 $35.77 $17,885
Kuczinski Anthony J Director June 11, 2026 Buy 2,500 $34.83 $87,075
Rogers John W Jr Director June 10, 2026 Buy 7,500 $35.16 $263,700
Ryan Patrick G Executive Chairman June 5, 2026 Buy 120,000 $32.50 $3.9M
Katz Mark Stephen EVP & General Counsel June 3, 2026 Buy 3,215 $31.07 $99,890
Hamilton Janice M Chief Financial Officer June 3, 2026 Buy 6,300 $31.79 $200,277
Ryan Patrick G Jr Director February 23, 2026 Buy 24,000 $39.94 $958,560
Ryan Patrick G Jr Director February 23, 2026 Buy 1,500 $40.20 $60,300
Ryan Patrick G Jr Director February 20, 2026 Buy 365 $41.41 $15,115
Turner Timothy William Chief Executive Officer December 12, 2025 Sell 129,570 $53.61 $6.9M

From insiders' Form 4 filings with the SEC. Excludes awards, option exercises and shares withheld for tax. "Pre-set plan" means the filing marks the trade as made under a Rule 10b5-1 plan. See every insider trade since five years ago, on a price chart.

Earnings dates and SEC filings

Results announcements

Next expected around February 11, 2027 estimated from the company's past filing pattern, not announced

  • October 29, 2026
  • July 30, 2026
  • April 30, 2026
  • February 12, 2026
  • October 30, 2025
  • July 31, 2025

Recent SEC filings

Data status

When each part of this page on Ryan Specialty Holdings, Inc. was last updated.

DataLast updatedSource
Share priceExchange closing prices
Financial statementsSEC 10-K and 10-Q filings
News and updatesCompany releases and SEC 8-K filings
Analyst estimatesAggregated analyst estimates
Valuation and scoresOur models, from the filed figures

How we build and check these figures: methodology and data sources.

Ryan Specialty Holdings, Inc. in brief

What does Ryan Specialty Holdings, Inc. do?
Ryan Specialty Holdings, Inc. is a US-listed company in the insurance brokers industry. Its financial year ends in December.
What is Ryan Specialty Holdings, Inc.'s stock ticker?
Ryan Specialty Holdings, Inc. trades under the ticker RYAN on NYSE. This page brings together its financial statements, valuation models, ownership and recent company updates.
What is Ryan Specialty Holdings, Inc.'s revenue, and how fast is it growing?
Over its most recent trailing twelve months, Ryan Specialty Holdings, Inc. reported revenue of $3.3B, 9.8% higher than a year earlier, according to its SEC filings.
What is Ryan Specialty Holdings, Inc.'s free cash flow?
Ryan Specialty Holdings, Inc.'s free-cash-flow margin is 17.5% of revenue over the trailing twelve months.
Who are Ryan Specialty Holdings, Inc.'s largest institutional shareholders?
By value reported in 13F filings for June 30, 2026, the largest reported holders are Blackrock, Inc., Vulcan Value Partners, LLC and T. Rowe Price Investment Management, Inc. 13F reports cover long US-listed positions of managers above $100M, filed up to 45 days after quarter end.
Does Ryan Specialty Holdings, Inc. pay a dividend?
Yes: Ryan Specialty Holdings, Inc. paid $64.4M in dividends over the trailing twelve months, a dividend yield of 1.16% and a payout ratio of 61.6%.
Who are Ryan Specialty Holdings, Inc.'s competitors?
In our Insurance Brokers peer group, the companies closest to Ryan Specialty Holdings, Inc. are Erie Indemnity, Baldwin Insurance Group, Inc., Selectquote, Inc., Brown & Brown and Hagerty, Inc. The side-by-side comparison below sets their revenue, margins and growth against Ryan Specialty Holdings, Inc.'s.
Are insiders buying or selling Ryan Specialty Holdings, Inc. stock?
Over the last 12 months, Ryan Specialty Holdings, Inc.'s directors and officers reported 9 open-market purchases and 4 sales on Form 4. The insider trading page charts every trade.
When is Ryan Specialty Holdings, Inc.'s next earnings date?
Around February 11, 2027, estimated from the spacing of its past results announcements (8-K filings). That is an estimate, not a confirmed date — Ryan Specialty Holdings, Inc. announces its own schedule.